Goltzman D, Peytremann A, Callahan E, Tregear G W, Potts J T
J Biol Chem. 1975 Apr 25;250(8):3199-203.
Two synthetic analogues of bovine parathyroid hormone (PTH) with NH2-terminal modifications, PTH-(3-34) and [desamino-Ala-1]PTH-(1-34), were found to lack agonist activity but to demonstrate antagonist properties when tested in the rat renal cortical adenylyl cyclase assay in vitro against the native hormone or against PTH-(1-34), the active synthetic NH2-terminal tetratriacontapeptide. The inhibition exhibited by these analogues was proportional in degree to the dose of inhibitor, abolished by oxidation of the analogue, reversible by addition of an excess of active hormone, and specific for parathyroid hormone-stimulated renal adenylyl cyclase. No inhibition of basal or sodium fluoride-stimulated renal adenylyl cyclase could be demonstrated. Two other synthetic bovine analogues, PTH-(13-34) and PTH-(1-26), were devoid of agonist and antagonist properties. The over-all results suggest that the requirements for receptor binding of parathyroid hormone are rather broad. Conformational factors or binding interactions involving specific residues, or both seem to require the entire sequence from residue 3 to residue 27 for receptor binding to occur. A dichotomy between receptor binding and adenylyl cyclase activation was demonstrated only by alterations or deletions involving the first 2 NH2-terminal residues of the hormone and emphasizes the importance of these residues in eliciting the biological activity of parathyroid hormone. The two antagonists, [desamino-Ala-1]PTH-(1-34) and PTH-(3-34), should be useful in further analysis of the initial steps in hormone action.
两种对牛甲状旁腺激素(PTH)进行氨基末端修饰的合成类似物,即PTH-(3 - 34)和[去氨基 - Ala - 1]PTH-(1 - 34),在体外大鼠肾皮质腺苷酸环化酶试验中,与天然激素或活性合成氨基末端三十四肽PTH-(1 - 34)相比,被发现缺乏激动剂活性,但具有拮抗剂特性。这些类似物所表现出的抑制作用在程度上与抑制剂剂量成正比,通过类似物的氧化可消除,通过添加过量活性激素可逆转,并且对甲状旁腺激素刺激的肾腺苷酸环化酶具有特异性。未发现对基础或氟化钠刺激的肾腺苷酸环化酶有抑制作用。另外两种合成牛类似物,PTH-(13 - 34)和PTH-(1 - 26),既没有激动剂特性也没有拮抗剂特性。总体结果表明,甲状旁腺激素受体结合的要求相当宽泛。涉及特定残基的构象因素或结合相互作用,或两者似乎都需要从第3位残基到第27位残基的整个序列才能发生受体结合。仅通过涉及激素前两个氨基末端残基的改变或缺失证明了受体结合与腺苷酸环化酶激活之间的二分法,并强调了这些残基在引发甲状旁腺激素生物活性中的重要性。这两种拮抗剂,[去氨基 - Ala - 1]PTH-(1 - 34)和PTH-(3 - 34),应有助于进一步分析激素作用的初始步骤。